Last reviewed · How we verify
An Open-Label Pilot Study Evaluating Synera® in the Treatment of Patients With Shoulder Impingement Syndrome
The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome
Details
| Lead sponsor | ZARS Pharma Inc. |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 20 |
| Start date | 2010-03 |
| Completion | 2010-09 |
Conditions
- Shoulder Impingement Syndrome
Interventions
- Heated lidocaine and tetracaine topical patch
Primary outcomes
- Pain intensity — Two weeks
Countries
United States